Hence the board decided to take this alone as far as they can...The longer they go alone the higher is the value..Yes ANP is struggling with finance but a massive Pharma market is at a stake and no big Pharma would let this happen...
Now with board still in plans for harmonize my the 2 biggest DMD markets....the value that can be created from this program could be massive...and very beneficial to any Pharma especially if they do not have to do the trials in the US..
Prof Voit didn't join ANP as PI for no reason..We just wait for our prize and possible treatment for the DMD patients.
IMO DYOR.
For General Information, page-28
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.5¢ |
Change
-0.001(1.32%) |
Mkt cap ! $67.61M | |||
| Open | High | Low | Value | Volume |
| 8.0¢ | 8.0¢ | 7.5¢ | $18.25K | 237.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 18038 | 7.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.9¢ | 120000 | 1 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.5¢ |
Change
-0.001 ( 2.60 %) |
||||
| Open | High | Low | Volume | ||
| 8.0¢ | 8.0¢ | 7.5¢ | 59548 | ||
| Last updated 15.20pm 10/05/2024 ? | |||||
| PER (ASX) Chart |